Table 1

Baseline characteristics of the general population and statin cohorts

 General population without CVD or diabetesStatin users
Men (n=1890530)Women (n=1917447)Men (n=161377)Women (n=139537)
Age at index date
 Mean (sd)49.5 (11.5)50.7 (12.0)58.8 (9.3)61 (8.6)
Duration of follow-up
 Mean (sd)3.9 (4)4.2 (4.2)4 (3.1)4.3 (3.3)
Ethnicity
 White (%)606447 (32.1)733075 (38.2)71624 (44.4)65291 (46.8)
 Black (%)19924 (1.1)23842 (1.2)873 (0.5)892 (0.6)
 Indian (%)12034 (0.6)13196 (0.7)1146 (0.7)902 (0.6)
 Other (%)26514 (1.4)32438 (1.7)1763 (1.1)1466 (1.1)
 Unknown (%)1225611 (64.8)1114896 (58.1)85971 (53.3)70986 (50.9)
Body mass index
 Low (<20) (%)27309 (1.4)83477 (4.4)1314 (0.8)2930 (2.1)
 Normal (≥20–<26) (%)379674 (20.1)570312 (29.7)34212 (21.2)35254 (25.3)
 Overweight (≥26) (%)508803 (26.9)559330 (29.2)81066 (50.2)67591 (48.4)
 Unknown (%)974744 (51.6)704328 (36.7)44785 (27.8)33762 (24.2)
Smoking status
 No (%)564673 (29.9)821574 (42.8)56895 (35.3)63491 (45.5)
 Past (%)239755 (12.7)230404 (12.0)43588 (27.0)25103 (18.0)
 Current (%)403422 (21.3)364550 (19.0)42204 (26.2)33034 (23.7)
 Unknown (%)682680 (36.1)500919 (26.1)18690 (11.6)17909 (12.8)
Systolic blood pressure
 Recorded (%)1205152 (63.7)1565999 (81.7)156004 (96.7)136138 (97.6)
 Mean (sd)132.6 (16.2)127.8 (18.0)141.9 (17.6)141.2 (18.7)
Cholesterol HDL ratio
 Recorded (%)336579 (17.8)353677 (18.4)123314 (76.4)104198 (74.7)
 Mean (sd)4.4 (1.3)3.7 (1.2)5.3 (1.5)4.7 (1.4)
Cholesterol
 Recorded (%)462057 (24.4)484668 (25.3)146672 (90.9)126441 (90.6)
 ≥6 mmol/l (%)125193 (27.1)150901 (31.1)94067 (64.1)101886 (80.6)
Number of GP records in year before
 Mean (sd)10.1 (15.2)16.3 (18.4)25.8 (18.5)32.1 (21.5)
Treated hypertension (%)155293 (8.2)191104 (10)71477 (44.3)65348 (46.8)
Atrial fibrillation (%)16275 (0.9)9742 (0.5)5170 (3.2)2751 (2.0)
Chronic renal disease (%)14729 (0.8)20943 (1.1)5173 (3.2)6323 (4.5)
Rheumatoid arthritis (%)8633 (0.5)21818 (1.1)1452 (0.9)3032 (2.2)
Left ventricular hypertrophy (%)5907 (0.3)3523 (0.2)2131 (1.3)1140 (0.8)